Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

CCytomX Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
C

CytomX Therapeutics, Inc.

$2.94Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $1.42M. Net result −$20.67M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $1.42M. Running result $1.42M. Revenue: $1.42M.
  • Cost of revenue: $0. Running result $1.42M.
  • Gross profit: $1.42M. Running result $1.42M.
  • Research and development: −$17.6M. Running result −$16.18M.
  • General and administrative: −$7.6M. Running result −$23.78M.
  • Operating income: −$23.78M. Running result −$23.78M.
  • Other income: $3.18M. Running result −$20.61M.
  • Pre-tax loss: −$20.61M. Running result −$20.61M.
  • Income tax expense: −$60K. Running result −$20.67M.
  • Net loss: −$20.67M. Running result −$20.67M.